Spinal cord dysmyelination induced in vivo by IgM antibodies to three different myelin glycolipids.
It was shown previously (Rosenbluth et al.: J. Neurosci. 16:2635-2641, 1996) that implantation of hybridoma cells that produce an IgM antigalactocerebroside into the spinal cord of young rats results in the development of myelin sheaths with a repeat period approximately 2-3x normal, similar to the abnormal peripheral myelin sheaths seen in human IgM gammopathies. We now present evidence that this effect can be reproduced in the spinal cord by implanting either of two other hybridomas, O4 and A2B5, that secrete, respectively, antisulfatide and antiganglioside IgM antibodies. The formation of expanded CNS myelin thus does not depend on antibodies to galactocerebroside specifically but can be mediated by IgM antibodies that react with other myelin glycolipids as well.
Rosenbluth
J
J
Department of Physiology and Neuroscience, Rusk Institute of Rehabilitation Medicine, New York University School of Medicine, New York 10016, USA.
Liang
W L
WL
Schiff
R
R
Dou
W K
WK
D000818:Animals; D003711:Demyelinating Diseases / Q000276:immunology*; D005699:Galactosylceramides / Q000276:immunology; D006801:Humans; D006825:Hybridomas / Q000737:chemistry / Q000276:immunology / Q000637:transplantation; D007075:Immunoglobulin M / Q000494:pharmacology*; D051379:Mice; D008854:Microscopy, Electron; D009185:Myelin Proteins / Q000276:immunology*; D009186:Myelin Sheath / Q000737:chemistry / Q000276:immunology / Q000648:ultrastructure; D051381:Rats; D013116:Spinal Cord / Q000737:chemistry / Q000276:immunology / Q000503:physiopathology*
D005699:Galactosylceramides; D007075:Immunoglobulin M; D009185:Myelin Proteins